Bio Green Med Solution(BGMS)
$0.57-0.02 (-2.71%)
BGMS
Bio Green Med Solution financials statements
$0.57
At close:-0.02 (-2.71%)
Want to see BGMS full AI Analyst Report?
Bio Green Med Solution (BGMS) Ratios
817 Followers
Bio Green Med Solution Ratios
BGMS's free cash flow for Q3 2026 was $-287.00K. For the 2026 fiscal year, BGMS's free cash flow was increased by $0.00 and operating cash flow was $-287.00K. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 4.70 | 0.59 | 0.91 | 3.25 | 7.56 |
| Quick Ratio | 3.66 | 0.59 | 0.91 | 3.25 | 7.56 |
| Cash Ratio | 2.63 | 0.50 | 0.41 | 2.44 | 6.75 |
| Solvency Ratio | -2.23 | -1.79 | -2.75 | -2.78 | -3.38 |
| Operating Cash Flow Ratio | -3.58 | -1.27 | -1.97 | -2.77 | -3.43 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ 4.91M | $ -2.59M | $ -754.00K | $ 16.79M | $ 35.50M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-Equity Ratio | 0.00 | 0.00 | 0.06 | 0.01 | 0.00 |
| Debt-to-Capital Ratio | 0.00 | 0.00 | 0.06 | 0.01 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.20 | -1.88 | 14.51 | 1.37 | 1.14 |
| Debt Service Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.00 | 0.00 | 10.44 | 33.91 | 12.10 |
| Net Debt to EBITDA | 0.42 | 0.26 | 0.13 | 0.66 | 1.63 |
| Profitability Margins | |||||
| Gross Profit Margin | 18.47% | 100.00% | 100.00% | 0.00% | 0.00% |
| EBIT Margin | -1128.11% | -27916.28% | -6060.24% | 0.00% | 0.00% |
| EBITDA Margin | -1127.44% | -27902.33% | -6052.86% | 0.00% | 0.00% |
| Operating Profit Margin | -1128.11% | -27916.28% | -6060.24% | 0.00% | 0.00% |
| Pretax Profit Margin | -400.40% | -27893.02% | -6083.57% | 0.00% | 0.00% |
| Net Profit Margin | -401.34% | -26074.42% | -5370.24% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | -401.34% | -26074.42% | -5370.24% | 0.00% | 0.00% |
| Net Income Per EBT | 100.23% | 93.48% | 88.27% | 81.80% | 83.20% |
| EBT Per EBIT | 35.49% | 99.92% | 100.39% | 93.70% | 99.09% |
| Return on Assets (ROA) | -36.63% | -273.86% | -256.16% | -75.57% | -42.79% |
| Return on Equity (ROE) | -43.82% | 515.73% | -3715.82% | -103.74% | -48.97% |
| Return on Capital Employed (ROCE) | -122.97% | 552.16% | -3952.33% | -134.65% | -59.35% |
| Return on Invested Capital (ROIC) | -122.97% | 515.92% | -3488.90% | -110.14% | -49.38% |
| Return on Tangible Assets | -45.32% | -273.86% | -256.16% | -75.57% | -42.79% |
| Earnings Yield | -92.71% | -8346.59% | -105689.08% | -112644.35% | -123676.76% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.59 | 0.18 | 0.11 | 0.00 | 0.00 |
| Payables Turnover | 0.99 | 0.00 | 0.00 | 0.01 | 0.02 |
| Inventory Turnover | 0.44 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 5.01 | 6.14 | 4.12 | 0.00 | 0.00 |
| Asset Turnover | 0.09 | 0.01 | 0.05 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.64 | -0.03 | 0.05 | 0.00 | 0.00 |
| Cash Conversion Cycle | 1073.89 | -277760.76 | 3237.20 | -29211.41 | -17969.88 |
| Days of Sales Outstanding | 614.20 | 2011.74 | 3237.20 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 829.49 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 369.79 | 279772.50 | 0.00 | 29211.41 | 17969.88 |
| Operating Cycle | 1443.69 | 2011.74 | 3237.20 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -2.18 | -358.07 | -4544.99 | -6662.51 | -7478.82 |
| Free Cash Flow Per Share | -2.18 | -358.07 | -4546.69 | -6664.75 | -7489.71 |
| Dividend Paid and CapEx Coverage Ratio | -78.20 | 0.00 | -77.84 | -100.13 | -81.32 |
| Capital Expenditure Coverage Ratio | 0.00 | 0.00 | -2685.33 | -2975.29 | -686.67 |
| Operating Cash Flow Coverage Ratio | -2385.00 | 0.00 | -435.46 | -196.48 | -618.00 |
| Operating Cash Flow to Sales Ratio | -6.39 | -185.81 | -38.36 | 0.00 | 0.00 |
| Free Cash Flow Yield | -147.50% | -5948.03% | -75526.34% | -110710.09% | -124413.85% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.23 | -0.01 | -0.00 | -0.00 | -0.00 |
| Price-to-Sales (P/S) Ratio | 4.33 | 3.12 | 0.05 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | 0.47 | -0.06 | 0.04 | 0.00 | 0.00 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -0.68 | -0.02 | -0.00 | -0.00 | -0.00 |
| Price-to-Operating Cash Flow Ratio | -0.68 | -0.02 | -0.00 | -0.00 | -0.00 |
| Price-to-Earnings Growth (PEG) Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Enterprise Value Multiple | 0.03 | 0.25 | 0.13 | 0.66 | 1.63 |
| Enterprise Value | -269.09K | -3.00M | -3.32M | -18.22M | -36.51M |
| EV to EBITDA | 0.03 | 0.25 | 0.13 | 0.66 | 1.63 |
| EV to Sales | -0.36 | -69.83 | -7.90 | 0.00 | 0.00 |
| EV to Free Cash Flow | 0.06 | 0.38 | 0.21 | 0.87 | 1.97 |
| EV to Operating Cash Flow | 0.06 | 0.38 | 0.21 | 0.87 | 1.97 |
| Tangible Book Value Per Share | 2.41 | -97.43 | 171.23 | 6536.47 | 15204.92 |
| Shareholders’ Equity Per Share | 3.13 | -97.43 | 171.23 | 6536.47 | 15204.92 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.00 | 0.07 | 0.12 | 0.18 | 0.17 |
| Revenue Per Share | 0.34 | 1.93 | 118.48 | 0.00 | 0.00 |
| Net Income Per Share | -1.37 | -502.46 | -6362.48 | -6781.19 | -7445.34 |
| Tax Burden | 1.00 | 0.93 | 0.88 | 0.82 | 0.83 |
| Interest Burden | 0.35 | 1.00 | 1.00 | 0.94 | 0.99 |
| Research & Development to Revenue | 1.14 | 154.77 | 45.61 | 0.00 | 0.00 |
| SG&A to Revenue | 10.33 | 125.40 | 16.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 3.12 | 13.77 | 3.51 | 0.00 | 0.00 |
| Income Quality | 1.59 | 0.71 | 0.71 | 0.98 | 1.00 |
Currency in USD

